Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update

Go back to Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $1.11 
Open $2.16    52 Week Low $0.41 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $-0.29 
Volume 5,346       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $1.11 
Open $2.16    52 Week Low $0.41 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $-0.29 
Volume 5,346